Literature DB >> 3525020

Reversal of central sleep apnea using nasal CPAP.

F G Issa, C E Sullivan.   

Abstract

Based on the theory that obstructive (OSA) and central (CSA) sleep apneas share common pathophysiologic mechanisms, we attempted to treat eight patients with predominantly CSA by continuous positive airway pressure (CPAP). All patients exhibited repetitive episodes of CSA and mixed sleep apneas (MSA) in the supine position with a mean duration of 23.7 +/- 0.7 s and 34.5 +/- 1.3 s, respectively. The pattern of apnea changed when the subject lay in the lateral position. Five patients were observed to develop OSA in the lateral position with a mean duration of 27.2 +/- 1.5 s, while the other three patients snored continuously. High levels of CPAP (range 9.0 to 16.5 cm H2O) prevented all CSA and MSA and resulted in quiet breathing in all eight patients. Intermediate levels of CPAP produced firstly MSA, then purely OSA and/or continuous snoring. Low levels of nasal CPAP also prevented OSA and snoring occurring in the lateral posture in all subjects (range 2.0 to 8.3 cm H2O). Three patients are currently on home CPAP therapy for a range of four to 36 months. We conclude that upper airway collapse in the supine posture has a key role in the induction of CSA. We suggest that a reflex inhibition of respiration through activation of supraglottic mucosal receptors during passive oropharyngeal airway closure caused CSA in these patients.

Entities:  

Mesh:

Year:  1986        PMID: 3525020     DOI: 10.1378/chest.90.2.165

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  36 in total

1.  Effective treatment for idiopathic central sleep apnea?

Authors:  Shilpa Rahangdale
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

Review 2.  The epidemiology of sleep apnoea.

Authors:  R J Davies; J R Stradling
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

Review 3.  Central sleep apnoea-a clinical review.

Authors:  Rexford T Muza
Journal:  J Thorac Dis       Date:  2015-05       Impact factor: 2.895

4.  Obstructive sleep apnea: therapeutic compliance.

Authors:  J P Baker; V Rose; C Ware
Journal:  Trans Am Clin Climatol Assoc       Date:  1988

Review 5.  Flow-regulatory function of upper airway in health and disease: a unified pathogenetic view of sleep-disordered breathing.

Authors:  S S Park
Journal:  Lung       Date:  1993       Impact factor: 2.584

Review 6.  Cheyne-stokes respiration in patients with heart failure.

Authors:  Laila AlDabal; Ahmed S BaHammam
Journal:  Lung       Date:  2009-12-03       Impact factor: 2.584

7.  Improvement of idiopathic central sleep apnea with zolpidem.

Authors:  Syed Quadri; Christopher Drake; David W Hudgel
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

8.  Treatment of central sleep apnea in U.S. veterans.

Authors:  Susmita Chowdhuri; Ahmed Ghabsha; Prabhat Sinha; Medina Kadri; Simranjit Narula; M Safwan Badr
Journal:  J Clin Sleep Med       Date:  2012-10-15       Impact factor: 4.062

9.  Treatment of sleep apnea in congestive heart failure with a dental device: the effect on brain natriuretic peptide and quality of life.

Authors:  Mahmoud Eskafi; Charles Cline; Maria Nilner; Bo Israelsson
Journal:  Sleep Breath       Date:  2006-06       Impact factor: 2.816

Review 10.  Central sleep apnea in patients with congestive heart failure.

Authors:  Safwan Badr
Journal:  Heart Fail Rev       Date:  2008-08-29       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.